Market Research Logo

Sweden Pharmaceuticals and Healthcare Report Q2 2016

Sweden Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Sweden's epidemiological profile will continue to be attractive to manufacturers of medicinesfor non-communicable diseases. Despite the relative rapid uptake of innovative pharmaceuticals, theburden of chronic conditions will increase over the next 15 years. Presenting a challenge to drugmakers,like many other developed states, Sweden is introducing cost-containment measures to restrict thecommercial opportunities available to drugmakers.

Headline Expenditure Projections

Pharmaceuticals: SEK39.50bn (USD4.68bn) in 2015 to SEK39.79bn (USD4.68bn) in 2016; +0.74% inlocal currency terms and -0.1% in US dollar terms.

Healthcare: SEK371.82bn (USD44.09bn) in 2015 to SEK381.68bn (USD44.88bn) in2016; +2.7% inlocal currency terms and 1.8% in US dollar terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Sweden 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Sweden 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Sweden 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Sweden 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Sweden 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Sweden 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Sweden 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Sweden 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Sweden 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Sweden 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Sweden 2014-2020)
Industry Risk/Reward Index
Western Europe Risk/Reward Index
Sweden Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Sweden 2010-2015)
Table: Healthcare Personnel (Sweden 2010-2015)
Table: Healthcare Activity (Sweden 2010-2015)
Research & Development
Table: Drug Development Member Companies of SwedenBIO, 2015
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
AstraZeneca
Meda
Medivir
Novartis
Swedish Orphan Biovitrum (SOBI)
Demographic Forecast
Table: Population Headline Indicators (Sweden 1990-2025)
Table: Key Population Ratios (Sweden 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Sweden 1990-2025)
Table: Population By Age Group (Sweden 1990-2025)
Table: Population By Age Group % (Sweden 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report